SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008347
Filing Date
2022-05-11
Accepted
2022-05-11 17:04:11
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20220331x10q.htm   iXBRL 10-Q 1017996
2 EX-31.1 capr-20220331xex31d1.htm EX-31.1 9521
3 EX-31.2 capr-20220331xex31d2.htm EX-31.2 9383
4 EX-32.1 capr-20220331xex32d1.htm EX-32.1 5742
5 EX-32.2 capr-20220331xex32d2.htm EX-32.2 5703
  Complete submission text file 0001558370-22-008347.txt   4502502

Data Files

Seq Description Document Type Size
6 EX-101.SCH capr-20220331.xsd EX-101.SCH 41987
7 EX-101.CAL capr-20220331_cal.xml EX-101.CAL 35491
8 EX-101.DEF capr-20220331_def.xml EX-101.DEF 138910
9 EX-101.LAB capr-20220331_lab.xml EX-101.LAB 300872
10 EX-101.PRE capr-20220331_pre.xml EX-101.PRE 244428
46 EXTRACTED XBRL INSTANCE DOCUMENT capr-20220331x10q_htm.xml XML 628508
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 22914624
SIC: 2834 Pharmaceutical Preparations